AU8585791A - Human ifn-beta 2/il-6, its purification and use - Google Patents
Human ifn-beta 2/il-6, its purification and useInfo
- Publication number
- AU8585791A AU8585791A AU85857/91A AU8585791A AU8585791A AU 8585791 A AU8585791 A AU 8585791A AU 85857/91 A AU85857/91 A AU 85857/91A AU 8585791 A AU8585791 A AU 8585791A AU 8585791 A AU8585791 A AU 8585791A
- Authority
- AU
- Australia
- Prior art keywords
- beta
- purification
- human ifn
- ifn
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL85204A IL85204A0 (en) | 1988-01-26 | 1988-01-26 | Recombinant human interferon beta2,its preparation and pharmaceutical compositions comprising it |
IL85204 | 1988-01-26 | ||
US193580 | 1988-05-13 | ||
IL88376 | 1988-11-14 | ||
IL88375 | 1988-11-14 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU28813/89A Division AU621852B2 (en) | 1988-01-26 | 1989-01-25 | Human ifn-beta 2/il-6, its purification and use |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU63008/94A Division AU676028B2 (en) | 1988-01-26 | 1994-05-11 | Human IFN-beta 2/IL-6, its purification and use |
Publications (2)
Publication Number | Publication Date |
---|---|
AU8585791A true AU8585791A (en) | 1992-01-23 |
AU651139B2 AU651139B2 (en) | 1994-07-14 |
Family
ID=11058509
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU85857/91A Expired AU651139B2 (en) | 1988-01-26 | 1991-10-16 | Human IFN-beta 2/IL-6, its purification and use |
AU63008/94A Expired AU676028B2 (en) | 1988-01-26 | 1994-05-11 | Human IFN-beta 2/IL-6, its purification and use |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU63008/94A Expired AU676028B2 (en) | 1988-01-26 | 1994-05-11 | Human IFN-beta 2/IL-6, its purification and use |
Country Status (3)
Country | Link |
---|---|
AU (2) | AU651139B2 (en) |
IL (1) | IL85204A0 (en) |
ZA (1) | ZA89585B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU639428B2 (en) * | 1988-12-01 | 1993-07-29 | Imclone Systems, Inc. | Synthetic interleukin-6 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3650715T2 (en) * | 1985-10-14 | 1999-06-24 | Yeda Research And Development Co., Ltd., Rehovot | Use of human interferon beta 2A for the manufacture of medicines |
IE67035B1 (en) * | 1986-07-08 | 1996-02-21 | Genetics Inst | Production and use of non-glycosylated IL-6 |
-
1988
- 1988-01-26 IL IL85204A patent/IL85204A0/en unknown
-
1989
- 1989-01-25 ZA ZA89585A patent/ZA89585B/en unknown
-
1991
- 1991-10-16 AU AU85857/91A patent/AU651139B2/en not_active Expired
-
1994
- 1994-05-11 AU AU63008/94A patent/AU676028B2/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU639428B2 (en) * | 1988-12-01 | 1993-07-29 | Imclone Systems, Inc. | Synthetic interleukin-6 |
Also Published As
Publication number | Publication date |
---|---|
ZA89585B (en) | 1989-10-25 |
IL85204A0 (en) | 1988-07-31 |
AU676028B2 (en) | 1997-02-27 |
AU651139B2 (en) | 1994-07-14 |
AU6300894A (en) | 1994-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU599400B2 (en) | Titanocenes and their use | |
JPS6419053A (en) | Novel peptide derivative, manufacture and use | |
AU3778389A (en) | Adjustable wrist and hand splint | |
AU1429488A (en) | Human interleukin-3 and muteins thereof | |
AU3072989A (en) | Skin treatment composition | |
GB8826113D0 (en) | Wheelchair | |
AU3502789A (en) | Composition and use | |
AU618865B2 (en) | Adenosin derivatives, their preparation and use | |
AU6292286A (en) | N-substituted-3,4,5,6,-tetrahydrophthalimides, their preparation and use | |
AU3553489A (en) | Novel compounds and treatment | |
IL92281A0 (en) | Polyimidesiloxanes,their preparation and use | |
AU587646B2 (en) | 5-aryl-2,4-dialkyl-3H-1,2,4-triazole-3-thiones and their use as antidepressants | |
AU3434489A (en) | Skin treatment formulations | |
EP0344109A3 (en) | Substituted naphthacene-5,12-diones and their use | |
AU3549489A (en) | Human gm-csf variants | |
IL86796A0 (en) | Peptide derivatives,their preparation and their use | |
GB8912373D0 (en) | Medicament for various skin and ulcer disorders | |
AU6300894A (en) | Human IFN-beta 2/IL-6, its purification and use | |
AU2681888A (en) | 8,9-annelated-beta-carbolines and 8,9-annelated-3,4-dihydro- beta-carbolines | |
NZ229274A (en) | 1,2-dithiol-3-thion-s-oxides and liver-protective medicaments | |
AU8129987A (en) | Pyrrolo-benzimidazoles, their preparation and use | |
AU581956B2 (en) | 6-chloro-3-methyl-1H-2,3,4,5-tetrahydro-3-benzazepine- N-oxide and medical compositions using it | |
AU5061990A (en) | Azacyclooctadiene compound and pharmaceutical use | |
AU5050490A (en) | Human monocyte-macrophage-csf preparations | |
AU4603289A (en) | Novel treatment |